- Since the start of the pandemic, Amazon has achieved an exponential increase in its number of sales.
- In recent years the company has been interested in the field of health and in the United States it already offers the sale of medicines with immediate home delivery.
- The aim of the vaccine is to work against breast cancer and melanoma.
Tumors have existed for thousands of years and today they have become one of the main causes of mortality in the world. It is one of the biggest public health problems, but thanks to recent innovations, treatments are now available. But now it is planned to achieve the most revolutionary advance by first cancer vaccine.
To put in context, the World Health Organization (WHO) points out that During 2020, almost 10 million deaths were recorded for this reason. While the trend continues to rise in most regions of the planet.
The most common and deadliest types of cancer
For its part, one of the main problems is that tumors can develop in any part of the body. Although according to statistics, the most common are those of breast, lung, colon and rectum and prostate.
Now, when analyzing the category of those that caused the most deaths during 2020, it is obtained that they were the following:
- Lung (1.8 million deaths).
- Colorectal (916,000 deaths).
- Hepatic (830,000 deaths).
- Gastric (769,000 deaths).
- Breast (685,000 deaths).
All of the above serves to demonstrate the dimension of the problem. For this reason, more and more companies are showing interest in the field of health. With this in mind, now Amazon teamed up with the Fred Hutchinson Cancer Research Center to finalize the clinical trial of a cancer vaccine.
According to information published by CNBC, the project arose in the Amazon’s Moonshot lab called the Grand Challenge. After obtaining satisfactory results in animals, permission has now been obtained from the United States Food and Drug Administration (FDA) to start a clinical trial in people.
According to the developers, this vaccine would work against breast cancer and melanoma. At the moment the call is already published in the National Library of Medicine to check if immunization repeats the results in people.
- Amazon is seeking to recruit 20 participants over the age of 18 for phase 1 of the trial.
- The Fred Hutchinson Cancer Research Center is listed as a sponsor of the study and Amazon as a collaborator.
- The study was first published in October 2021 and began on June 9. It is expected to be complete by November 1, 2023.
Amazon brings its technology to the field of health
On the other hand, in recent years Amazon has established itself as the largest giant in internet sales. For the same, It has also been interested in other markets and health is one of the main ones.
In this case, in 2020 he started his project of an online pharmacy that offers immediate home delivery. At the moment it is only available in the United States but it is expected that in the medium term it will also reach other territories.
Similarly, the company has also increased its telehealth service called AmazonCare and with its technological team it has focused on the development of medical devices.